OpenVSafe by OpenVAERS
Search V-safe

45Z-27087-72315

5 vaccinations 14 coded responses 64 check-ins 14 free-text entries 6 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
925 / CA
Registered
2021-03-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
RCN-42068-30038 Other · Male · 2021-08-24

Timeline

  1. 2021-03-02
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-04
    Registered in v-safe
  3. 2021-03-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  4. 2021-03-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  5. 2021-03-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Nausea
    Adult check-in
  6. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-03-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-09
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-16
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-03-23
    Survey response — day 21, dose 1
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: I have MCTD, my symptoms are in line with a general flare of my autoimmune disease.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-24
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-24
    Survey response — day 0, dose 2
    MedDRA: Nasal congestion, Throat irritation — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Throat irritation, stuffy nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Musculoskeletal stiffness, Throat irritation — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Stiff neck and throat irritation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Musculoskeletal stiffness, Pharyngeal swelling — Feeling: Fair · Site: Pain, Redness, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Stiff neck, sensation of swelling in my throat - but not severe.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Musculoskeletal stiffness — Feeling: Good · Site: Pain, Redness, Itching · Muscle or body aches, Fatigue or tiredness
    Free text: Stiff neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Musculoskeletal stiffness — Feeling: Good · Site: Pain, Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Stiff neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  18. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Poor · Site: Pain, Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: I have autoimmune disease, so the symptoms may not be related to getting the vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-31
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain, Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-04-07
    Survey response — day 14, dose 2
    MedDRA: Balance disorder, Coordination abnormal, Dry eye, Dysaesthesia, Dyspnoea, Muscular weakness, Paraesthesia, Pre-existing disease, Vision blurred — Feeling: Good
    Free text: I have MCTD and Im having various symptoms related to that. SOB, muscle weakness, paresthesia. dyesthesia, balance and coordination problems, blurry vision/dry eyes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-14
    Survey response — day 21, dose 2
    MedDRA: Condition aggravated, Dysaesthesia, Dyspepsia, Insomnia, Muscle spasms, Office visit, Paraesthesia, Pre-existing disease, Respiration abnormal, Vision blurred — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: I have NCTD and am experiencing a flare that includes problems with breathing, digestion, paresthesia, dyesthesia, insomnia, muscle spans and blurry vision. · Healthcare visit (other): In person appointment and diagnostic tests (chest x-ray, pulmonary function test, and sleep study have been scheduled.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-04-14
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-04-21
    Survey response — day 28, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I continue to have an exacerbation of breathing difficulties and insomnia. May be related to lung disease secondary to MCTD.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-04-21
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-04-28
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-05-05
    Survey response — day 42, dose 2
    MedDRA: Condition aggravated, Pre-existing disease, Respiratory disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Increased breathing problems related to ACOS (I have MCTD)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-05-05
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-06-23
    Survey response — 3 months, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Exacerbation from my MCTD.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-06-23
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2021-06-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  31. 2021-06-28
  32. 2021-06-29
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  33. 2021-06-29
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  34. 2021-06-29
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  35. 2021-08-24
    Dose 3 — Pfizer-BioNTech
  36. 2021-08-24
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  37. 2021-08-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness · Headache
    Adult check-in
  38. 2021-08-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  39. 2021-08-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  40. 2021-08-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Itching · None
    Adult check-in
  41. 2021-08-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  42. 2021-08-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  43. 2021-08-31
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  44. 2021-09-07
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  45. 2021-09-14
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  46. 2021-09-21
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  47. 2021-09-28
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  48. 2021-10-05
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  49. 2021-11-23
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  50. 2022-02-22
    Survey response — 6 months, dose 3
    MedDRA: Myositis, Neuritis, Pre-existing disease, Secretion discharge — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Massive amounts of mucus production in my airway, and inflammation of muscles and nerves. But I have Mixed Connective Tissue Disease, so it probably all related to that.
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-02-22
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  52. 2022-02-23
  53. 2022-03-28
    Dose 4 — Pfizer-BioNTech
  54. 2022-03-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  55. 2022-03-31
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  56. 2022-04-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  57. 2022-04-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  58. 2022-04-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Swelling, Itching · Headache
    Adult check-in
  59. 2022-04-04
    Health check-in — day 7, dose 4
    Feeling: Good · Site: Itching · Headache
    Adult check-in
  60. 2022-04-11
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  61. 2022-04-18
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  62. 2022-04-25
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  63. 2022-05-02
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  64. 2022-05-09
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  65. 2022-06-27
    Health check-in — 3 months, dose 4
    Feeling: Fair
    Adult check-in
  66. 2022-09-26
    Survey response — 6 months, dose 4
    MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID August 2022
    MedDRA releases: 2024-11 · check-in free text available
  67. 2022-09-26
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  68. 2022-09-28
  69. 2022-09-28
  70. 2023-01-20
    Dose 5 — Pfizer-BioNTech
  71. 2023-01-20
    Health check-in — day 0, dose 5
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  72. 2023-01-21
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  73. 2023-01-22
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  74. 2023-01-23
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  75. 2023-01-24
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  76. 2023-01-25
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness
    Adult check-in
  77. 2023-01-26
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  78. 2023-01-27
    Health check-in — day 7, dose 5
    Feeling: Good · Site: Itching · Fatigue or tiredness
    Adult check-in
  79. 2023-02-03
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  80. 2023-02-10
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  81. 2023-02-17
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  82. 2023-02-24
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  83. 2023-03-03
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  84. 2023-04-21
    Health check-in — 3 months, dose 5
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-02Pfizer-BioNTech
22021-03-24Pfizer-BioNTech
32021-08-24Pfizer-BioNTech No
42022-03-28Pfizer-BioNTech No
52023-01-20Pfizer-BioNTech No

Call center

6 call center cases

4 successful · 2 unsuccessful

See the call center timeline

Free text

Release 6 — day 21, dose 1

2021-03-23

Symptoms: I have MCTD, my symptoms are in line with a general flare of my autoimmune disease.

Release 6 — day 0, dose 2

2021-03-24

Systemic reaction (other): Throat irritation, stuffy nose

Release 6 — days 1–6 daily, dose 2

2021-03-25

Systemic reaction (other): Stiff neck and throat irritation.

2021-03-26

Systemic reaction (other): Stiff neck, sensation of swelling in my throat - but not severe.

2021-03-27

Systemic reaction (other): Stiff neck

2021-03-28

Systemic reaction (other): Stiff neck

2021-03-30

Systemic reaction (other): I have autoimmune disease, so the symptoms may not be related to getting the vaccine.

Release 7 — day 14, dose 2

2021-04-07

Symptoms: I have MCTD and Im having various symptoms related to that. SOB, muscle weakness, paresthesia. dyesthesia, balance and coordination problems, blurry vision/dry eyes.

Release 7 — day 21, dose 2

2021-04-14

Symptoms: I have NCTD and am experiencing a flare that includes problems with breathing, digestion, paresthesia, dyesthesia, insomnia, muscle spans and blurry vision.
Healthcare visit (other): In person appointment and diagnostic tests (chest x-ray, pulmonary function test, and sleep study have been scheduled.

Release 7 — day 28, dose 2

2021-04-21

Symptoms: I continue to have an exacerbation of breathing difficulties and insomnia. May be related to lung disease secondary to MCTD.

Release 8 — day 42, dose 2

2021-05-05

Symptoms: Increased breathing problems related to ACOS (I have MCTD)

Release 9 — 3 months, dose 2

2021-06-23

Symptoms: Exacerbation from my MCTD.

Release 11 — 6 months, dose 3

2022-02-22

Symptoms: Massive amounts of mucus production in my airway, and inflammation of muscles and nerves. But I have Mixed Connective Tissue Disease, so it probably all related to that.

Release 12 — 6 months, dose 4

2022-09-26

Symptoms: COVID August 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDBalance disorder ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDCoordination abnormal ✓ ✓ ✓
SDCOVID-19 · · ✓
SDDry eye ✓ ✓ ✓
SDDysaesthesia ✓ ✓ ✓
SDDyspepsia ✓ · ✓
SDDyspnoea ✓ ✓ ✓
SDInsomnia ✓ ✓ ✓
SDMuscle spasms ✓ ✓ ✓
SDMuscular weakness ✓ ✓ ✓
SDMyositis · · ✓
SDNeuritis · · ✓
SDParaesthesia ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRespiration abnormal ✓ ✓ ✓
SDRespiratory disorder ✓ ✓ ✓
SDSecretion discharge · · ✓
SDVision blurred ✓ ✓ ✓
SROMusculoskeletal stiffness ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SROPharyngeal swelling ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROThroat irritation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release